BDMCX
Price
$12.81
Change
-$0.02 (-0.16%)
Updated
Nov 8 closing price
BGCKX
Price
$14.24
Change
-$0.02 (-0.14%)
Updated
Nov 8 closing price
Ad is loading...

BDMCX vs BGCKX

Header iconBDMCX vs BGCKX Comparison
Open Charts BDMCX vs BGCKXBanner chart's image
BlackRock Global Equity Mkt Netrl C
Price$12.81
Change-$0.02 (-0.16%)
VolumeN/A
CapitalizationN/A
BlackRock Global Equity Mkt Netrl K
Price$14.24
Change-$0.02 (-0.14%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
BDMCX vs BGCKX Comparison Chart
Loading...
VS
BDMCX vs. BGCKX commentary
Nov 10, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BDMCX is a Hold and BGCKX is a Hold.

FUNDAMENTALS
Fundamentals
BDMCX (2.57B) and BGCKX (2.57B) have equal amount of cash in the bank . BGCKX pays higher dividends than BDMCX: BGCKX (6.83) vs BDMCX (6.49). BDMCX was incepted earlier than BGCKX: BDMCX (12 years) vs BGCKX (9 years). BDMCX (79.00) and BGCKX (79.00) have comparable annual turnover. BDMCX has a lower initial minimum investment than BGCKX: BDMCX (1000) vs BGCKX (5000000). BGCKX annual gain was more profitable for investors over the last year : 24.85 vs. BDMCX (23.47). BGCKX return over 5 years is better than : 33.27 vs. BDMCX (26.89).
BDMCXBGCKXBDMCX / BGCKX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence12 years9 years-
Gain YTD19.40120.60594%
Front LoadN/AN/A-
Min. Initial Investment100050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets2.57B2.57B100%
Annual Yield % from dividends6.496.8395%
Returns for 1 year23.4724.8594%
Returns for 3 years36.2640.5889%
Returns for 5 years26.8933.2781%
Returns for 10 years27.00N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NXPL1.140.05
+4.58%
NextPlat Corp
DGII32.330.33
+1.05%
Digi International
XYL124.370.71
+0.57%
Xylem
M15.67-0.78
-4.74%
Macy's
FATE2.41-0.13
-5.29%
Fate Therapeutics